drugset

drugset / Trial / NCT00184587

Prophylactic Treatment of Episodic Cluster Headache

NCT00184587 ↗

Phase 2 Completed 40 enrolled Norwegian University of Science and Technology AstraZeneca · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether candesartan cilexetil are effective prophylactic treatment of episodic Cluster headache

Timeline

Start: 2005-03
Primary completion: 2009-06
Completion: 2009-12

Publications

Background Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA. 2003 Jan 1;289(1):65-9. doi: 10.1001/jama.289.1.65.
Results Tronvik E, Wienecke T, Monstad I, Dahlof C, Boe MG, Tjensvoll AB, Salvesen R, Zwart JA, Jansson SO, Stovner LJ. Randomised trial on episodic cluster headache with an angiotensin II receptor blocker. Cephalalgia. 2013 Sep;33(12):1026-34. doi: 10.1177/0333102413484989. Epub 2013 Apr 18.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Candesartan cilexetil	Unknown	32 mg	—

Indications